Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CDC7 | O00311 | 9/20 | 0.55 |
| ▸ | DBF4 | Q9UBU7 | 9/20 | 0.55 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | PI4KA | P42356 | 2/20 | 0.48 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.48 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.48 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.48 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31606731 | 0.80 | G6PD (1.00) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL2888994 | 0.80 | G6PD (1.00) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL1884553 | 0.77 | G6PD (0.71) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL28322010 | 0.77 | G6PD (0.71) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL240980 | 0.77 | HSD17B10 (1.00) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL30132912 | 0.77 | HSD17B10 (1.00) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL2891519 | 0.76 | MAP3K5 (0.64) | HSD17B10TP53HIF1ACYP1A2CYP3A4 | |
| SCHEMBL10840233 | 0.76 | HSD17B10 (0.96) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL10840236 | 0.76 | HSD17B10 (0.96) | G6PDHSD17B10TP53CDC7DBF4 | |
| SCHEMBL1607122 | 0.73 | PI4KA (0.52) | G6PDHSD17B10TP53CDC7DBF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286084-A1 | Oligomer-Nucleoside Phosphate Conjugates | NEKTAR THERAPEUTICS (US) | 2010-11-11 | — | — | US | claimed |
| WO-2009042064-A2 | OLIGOMER-NUCLEOSIDE PHOSPHATE CONJUGATES | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2009-04-02 | — | — | WO | claimed |
| US-9365604-B2 | Oligomer-nucleoside phosphate conjugates | NEKTAR THERAPEUTICS (US) | 2016-06-14 | — | — | US | disclosed |
| US-20140371168-A1 | OLIGOMER-NUCLEOSIDE PHOSPHATE CONJUGATES | NEKTAR THERAPEUTICS (US) | 2014-12-18 | — | — | US | disclosed |
| US-8741858-B2 | Oligomer-nucleoside phosphate conjugates | NEKTAR THERAPEUTICS | 2014-06-03 | — | — | US | disclosed |
| US-20100286084-A1 | Oligomer-Nucleoside Phosphate Conjugates | NEKTAR THERAPEUTICS (US) | 2010-11-11 | — | — | US | disclosed |
| WO-2009042064-A2 | OLIGOMER-NUCLEOSIDE PHOSPHATE CONJUGATES | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2009-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371168-A1 | OLIGOMER-NUCLEOSIDE PHOSPHATE CONJUGATES | ENTPD5, SLC29A2, SLC29A1 | G6PD 1540/4885HSD17B10 4590/4885TP53 828/4885 |
| US-20100286084-A1 | Oligomer-Nucleoside Phosphate Conjugates | ENTPD5, SLC29A2, SLC29A1 | G6PD 1461/4885HSD17B10 4537/4885TP53 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.